(Press-News.org) Conservative fuel treatments designed to reduce fire severity while still providing forest cover and wildlife habitat worked equally as well as more intensive treatments in allowing for the protection of homes during the 2011 Wallow Fire, a study published in the journal Forest Ecology and Management has found. The distance into the treated area where fire severity was reduced varied, however, between these different thinning approaches where fuels were reduced. The findings suggest that there may be multiple paths to fuel treatment design around the wildland-urban interface (WUI).
"Fuel reduction treatments are designed to reduce fire behavior and provide firefighters with safer opportunities to spot-protect homes, and qualitative observations during the Wallow Fire suggest previously implemented treatments did just that," said Morris Johnson, a research fire ecologist with the U.S. Forest Service's Pacific Northwest Research Station, and co-lead of the study. "Our study is the first to look quantitatively at how treatments actually performed around the wildland-urban interface during this major wildfire."
The Wallow Fire is the largest in Arizona state history, having burned over 539,000 acres between May and June 2011. Parts of the landscape that burned during the Wallow Fire previously underwent fuel reduction treatments as part of the White Mountain Stewardship Contract following another massive fire, the Rodeo-Chediski Fire, which destroyed 465 homes in 2002. This management history gave researchers an unexpected opportunity to study how effective two alternative fuel treatments were in reducing the fire's severity, particularly in the WUI, a critical area on the landscape where a forest or wildland intersects development.
Johnson and study lead Maureen Kennedy, a University of Washington research scientist, studied three previously treated areas in two WUI communities within the Wallow Fire perimeter—Alpine and Nutrioso—that burned during the fire and were not subject to fire suppression efforts. Two of the forested areas, the ones surrounding the community of Alpine, were thinned in 2004 with a primary goal of reducing fire severity through the removal of all ladder fuels and snags and the creation of an open canopy with wide, even spacing. In contrast, the forested area adjacent to the neighboring community of Nutrioso was thinned in 2010 with a goal of not only reducing fire severity, but of maintaining pockets of dense forest cover and associated wildlife habitat.
To characterize fire severity, the researchers established linear transects through each of these three study areas a year after the Wallow Fire. The transects ran in the direction of the fire's spread, from untreated to treated areas, and so represented a continuum of fire severity. The researchers then classified trees in each area based on the amount of fire damage they had sustained, using measures like crown scorch and bole char, and then ran statistical analyses that compared the relationship between severity measures and distance along the transect.
The study's findings showed that fire severity was reduced as the fire moved from untreated to treated areas, evidenced by the fire transitioning from a crown fire to a ground fire. But the distance at which the reduction occurred differed, depending on the intensity of the fuel treatment. The Alpine treatment area, which was more intensively thinned, achieved a spatially rapid reduction in severity, while the Nutrioso area required a wider area, although reduction was achieved before the fire reached the adjacent community. This would suggest that the greater a fuel treatment's emphasis on wildlife habitat and aesthetic considerations, the larger the size of treatment area needed to realize a reduction in fire severity. Both thinning prescriptions permitted firefighters to safely access the communities to extinguish fire starts and spot-protect homes.
"Our findings suggest that fuel treatments that promote wildlife habitat and aesthetics are still potentially successful in sufficiently reducing fire severity to provide opportunities to protect residences in the WUI during a fire," said Kennedy. "Although this case study refers to just these treatments in this particular fire, it does point to the possibility that there are multiple paths to effective fuel treatments."
INFORMATION:
The Pacific Northwest Research Station—headquartered in Portland, Ore.—generates and communicates scientific knowledge that helps people make informed choices about natural resources and the environment. The station has 11 laboratories and centers located in Alaska, Washington, and Oregon and about 400 employees. Learn more online at http://www.fs.fed.us/pnw.
Wallow Fire study suggests there may be multiple paths to fuel reduction in the WUI
Alternative fuel treatments both reduced fire behavior, allowed for protection of homes
2014-05-30
ELSE PRESS RELEASES FROM THIS DATE:
A first for NASA's IRIS: Observing a gigantic eruption of solar material
2014-05-30
VIDEO:
A coronal mass ejection burst off the side of the sun on May 9, 2014. The giant sheet of solar material erupting was the first CME seen by NASA's Interface...
Click here for more information.
A coronal mass ejection, or CME, surged off the side of the sun on May 9, 2014, and NASA's newest solar observatory caught it in extraordinary detail. This was the first CME observed by the Interface Region Imaging Spectrograph, or IRIS, which launched in June 2013 to peer into ...
Myriad presents data on BRACAnalysis CDx and HRD at 2014 ASCO meeting
2014-05-30
SALT LAKE CITY, Utah, May 30, 2014 – Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in molecular diagnostics, announced the presentation of new data at the American Society of Clinical Oncology (ASCO) meeting this week that supports the clinical efficacy of its BRACAnalysis CDx™ and HRD™ tests in predicting platinum based therapy response for breast cancer patients. Additionally, the company is providing an update on key commercial milestones that underscore its commitment to the field of companion diagnostics.
"Myriad is committed to advancing the science of companion ...
New method of wormlike motion lets gels wiggle through water
2014-05-30
Next time you spot an earthworm sliding through fresh dirt, take a closer look. What you're seeing is an organic movement called peristaltic locomotion that has been meticulously refined by nature.
Jarod Gregory, an undergraduate student in the University of Cincinnati's College of Engineering and Applied Science, used a worm's contracting and expanding motion to provide a way for gels to swim in water. This is a product of work by the interdisciplinary team consisting of Jarod Gregory, a chemical engineering major, and his two advisers, Lilit Yeghiazarian, assistant ...
New drug treatment helps prevent early menopause in breast cancer patients
2014-05-30
MAYWOOD, Ill. (May 30, 2014) – Among young women treated for breast cancer, one of the most distressing side effects of chemotherapy is early menopause. But a major clinical trial has found that the risk of early menopause can be significantly reduced by adding a drug called goserelin to the chemotherapy regimen. Also, women who took goserelin and wanted to have children were more likely to get pregnant and deliver a healthy baby.
Results were released during the 2014 American Society of Clinical Oncology 50th Annual Meeting in Chicago. Kathy Albain, MD, of Loyola University ...
Stopping statins may benefit terminally ill patients
2014-05-30
Results presented today at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) and June 6 at the European Association of Palliative Care Research Conference show that stopping statins for cholesterol management in the late stages of cancer or other terminal illnesses may offer quality-of-life and even life-extending benefits. The results highlight the larger question of when, if ever, it is appropriate in patients with life-limiting illnesses to discontinue medications prescribed for other conditions that will likely not lead to their death.
Researchers ...
Women with metastatic breast cancer can safely receive bisphosphonates less frequently, without comp
2014-05-30
CHICAGO – Women with metastatic breast cancer to the bone may be able to receive bisphosphonates, the bone-targeting class of drugs like zoledronic acid, less often after the first year of monthly administration. With that practice change, women may also reduce their risk of serious side effects, according to a study led by researchers at The University of Texas MD Anderson Cancer Center.
The research was presented today on the press program of the American Society of Clinical Oncology 2014 Annual Meeting by MD Anderson's Gabriel Hortobagyi, MD, professor, Breast Medical ...
Phase I study of DMOT4039A in patients with pancreatic or ovarian cancer
2014-05-30
A study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) describes the results of a phase I clinical trial of the investigational agent DMOT4039A against pancreatic and ovarian cancers. In this early clinical trial with the goal of identifying possible risks and defining likely dosages, the drug was well tolerated and in some patients showed initial evidence of anti-cancer activity.
The drug is in fact a combination of a chemotherapeutic agent with an antibody, technically called an antibody-drug conjugate (ADC). Just as cells ...
Genetic profile predicts which bladder cancer patients will benefit from early chemotherapy
2014-05-30
CHICAGO, IL (May 30, 2014)—Three genetic changes can predict whether a patient will benefit from chemotherapy before surgery to remove bladder cancer, according to new findings presented by Fox Chase Cancer Center researchers during the 50th Annual Meeting of the American Society of Clinical Oncology.
During the study, 36 patients with muscle-invasive bladder cancer received chemotherapy before surgery, consisting of an accelerated regimen of methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC). By the time surgery rolled around, 14 patients appeared cancer-free. ...
For the first time in the lab, researchers see stem cells take key step toward development
2014-05-30
CHAMPAIGN, Ill. — The gap between stem cell research and regenerative medicine just became a lot narrower, thanks to a new technique that coaxes stem cells, with potential to become any tissue type, to take the first step to specialization. It is the first time this critical step has been demonstrated in a laboratory.
University of Illinois researchers, in collaboration with scientists at Notre Dame University and the Huazhong University of Science and Technology in China, published their results in the journal Nature Communications.
"Everybody knows that for an embryo ...
Trial uncovers potential dangers of chemotherapy regimen for bladder cancer patients
2014-05-30
CHICAGO, IL (May 30, 2014)—Patients with muscle-invasive bladder cancer often benefit from chemotherapy before surgery to remove the tumor, but a test of one regimen by researchers at Fox Chase Cancer Center was halted when too many people experienced serious side effects such as heart attacks and blood clots in the legs and lungs.
All of the 31 patients included in the study received a combination of gemcitabine and cisplatin, two drugs normally administered for 12 weeks before surgery to remove the tumors. This became the standard of care after one study looked back, ...
LAST 30 PRESS RELEASES:
Megalodon’s body size and form uncover why certain aquatic vertebrates can achieve gigantism
A longer, sleeker super predator: Megalodon’s true form
Walking, moving more may lower risk of cardiovascular death for women with cancer history
Intracortical neural interfaces: Advancing technologies for freely moving animals
Post-LLM era: New horizons for AI with knowledge, collaboration, and co-evolution
“Sloshing” from celestial collisions solves mystery of how galactic clusters stay hot
Children poisoned by the synthetic opioid, fentanyl, has risen in the U.S. – eight years of national data shows
USC researchers observe mice may have a form of first aid
VUMC to develop AI technology for therapeutic antibody discovery
Unlocking the hidden proteome: The role of coding circular RNA in cancer
Advancing lung cancer treatment: Understanding the differences between LUAD and LUSC
Study reveals widening heart disease disparities in the US
The role of ubiquitination in cancer stem cell regulation
New insights into LSD1: a key regulator in disease pathogenesis
Vanderbilt lung transplant establishes new record
Revolutionizing cancer treatment: targeting EZH2 for a new era of precision medicine
Metasurface technology offers a compact way to generate multiphoton entanglement
Effort seeks to increase cancer-gene testing in primary care
Acoustofluidics-based method facilitates intracellular nanoparticle delivery
Sulfur bacteria team up to break down organic substances in the seabed
Stretching spider silk makes it stronger
Earth's orbital rhythms link timing of giant eruptions and climate change
Ammonia build-up kills liver cells but can be prevented using existing drug
New technical guidelines pave the way for widespread adoption of methane-reducing feed additives in dairy and livestock
Eradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
New study finds that tooth size in Otaria byronia reflects historical shifts in population abundance
nTIDE March 2025 Jobs Report: Employment rate for people with disabilities holds steady at new plateau, despite February dip
Breakthrough cardiac regeneration research offers hope for the treatment of ischemic heart failure
Fluoride in drinking water is associated with impaired childhood cognition
New composite structure boosts polypropylene’s low-temperature toughness
[Press-News.org] Wallow Fire study suggests there may be multiple paths to fuel reduction in the WUIAlternative fuel treatments both reduced fire behavior, allowed for protection of homes